Virtus Health Ltd expands to the UK

Virtus Health Ltd (ASX:VRT) announced that it is expanding to the UK.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Virtus Health Ltd (ASX: VRT) is Australia's largest assisted reproductive provider.

Earlier today, Virtus announced that it will be expanding into the UK.

The IVF company has exchanged contracts for the acquisition of 90% of the ordinary share capital of Complete Fertility Limited based at the Princess Anne Hospital in Southampton for a 'cash free debt free' consideration of approximately £5 million ($8.8 million) at a multiple of approximately seven times normalised FY17 earnings before interest, tax, depreciation and amortisation (EBITDA).

The 'cash free debt free' consideration is funded from existing cash and debt resources.

The transaction also includes an agreement for Complete Fertility to acquire the business and assets relating to fertility services by the University Hospital Southampton NHS Foundation Trust.

Virtus Health CEO, Sue Channon, said "The UK is a target market for Virtus and this acquisition adds to Virtus' international growth strategy reaffirming our vision for diversification and expansion of the Virtus model in carefully selected international markets."

"CFL is highly regarded in the UK providing fertility treatments to NHS and private patients and its clinicians are at the forefront of research and development in the area of assisted reproductive services".

Virtus said that CFL performed 420 fresh IVF cycles in the year ended 31 March 2017 and has achieved further growth during the nine months to December 2017.

The centre is located on the south coast of the Britain and has around 50% of the regional market share. Virtus believes it offers significant opportunity for future growth.

Foolish takeaway

Virtus expect that this acquisition will be earnings per share (EPS) accretive in FY19. This seems like a clever acquisition and will give Virtus a foothold into the large UK market. It's currently trading at 14x FY18's estimated earnings with a grossed-up dividend yield of 6.77%.

I think Virtus offers investors an attractive long-term growth opportunity at the current price and is worth further research.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Virtus Health Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »